Literature DB >> 27110047

Time Course of Macular and Peripapillary Inner Retinal Thickness in Non-arteritic Anterior Ischaemic Optic Neuropathy Using Spectral-Domain Optical Coherence Tomography.

Katsutoshi Goto1, Atsushi Miki2, Syunsuke Araki3, Kenichi Mizukawa3, Masaki Nakagawa3, Go Takizawa3, Yoshiaki Ieki3, Junichi Kiryu3.   

Abstract

To report a time course of the ganglion cell complex (GCC) and circumpapillary retinal nerve fibre layer (cpRNFL) thicknesses using spectral-domain optical coherence tomography in patients with non-arteritic anterior ischaemic optic neuropathy (NAION), five patients with unilateral NAION were studied (the average age of 66.8 ± 7.8 years old). Forty-one age-matched normal controls were also enrolled. The GCC and cpRNFL thicknesses were measured at the initial visit and at 1, 3, 6, and 12 months using RTVue-100. The GCC thickness and the cpRNFL thickness of the patients were compared with those of the normal controls. The GCC thickness in the NAION patients was 96.49 μm at the initial visit, 84.28 μm at 1 month, 74.26 μm at 3 months, 71.23 μm at 6 months, and 69.51 μm at 12 months. The values at 1, 3, 6, and 12 months were significantly reduced (p < 0.01). The cpRNFL thickness at the initial visit was significantly increased, whereas the values at 6 and 12 months were significantly reduced (p < 0.01). The GCC thickness is more useful for the detection of retinal ganglion cell loss at an early stage than the cpRNFL thickness, because the GCC thickness is unaffected by optic disc swelling at the initial visit, unlike the cpRNFL thickness.

Entities:  

Keywords:  Anterior ischaemic optic neuropathy; ganglion cell complex; retinal ganglion cell; retinal nerve fibre layer; spectral-domain optical coherence tomography

Year:  2016        PMID: 27110047      PMCID: PMC4819921          DOI: 10.3109/01658107.2015.1136654

Source DB:  PubMed          Journal:  Neuroophthalmology        ISSN: 0165-8107


Introduction

Non-arteritic anterior ischaemic optic neuropathy (NAION) is caused by ischaemia in the peripheral side of the lamina cribrosa of the optic disc, which leads to indolent acute unilateral visual loss. NAION is often observed in middle-aged patients older than 50 years old with a sudden onset of painless unilateral visual loss. The main visual field defects observed are inferior altitudinal visual field defects and a central scotoma.[2,3] The risk factors for the development of the disease are hypertension, arteriosclerosis, diabetes, cardiovascular disease, and internal carotid artery occlusion. These factors may result in axonal swelling when the flow of axons is inhibited by dense axons in the lamina cribrosa of small optic discs. The axonal swelling tends to occur in crowded optic discs.– Optical coherence tomography (OCT) is a non-invasive imaging technique that makes it easy to obtain retinal tomographic images, and is also capable of quantifying the circumpapillary retinal nerve fibre layer (cpRNFL). Several studies of the cpRNFL thickness using OCT in patients with NAION have been reported.– However, the presence of retinal ganglion cell loss at an early stage may be masked by a significantly increased cpRNFL thickness in patients with NAION due to severe optic disc swelling. Therefore, cpRNFL thickness measurements may not be able to detect the retinal ganglion cell loss at an early stage in NAION. Spectral-domain (SD) OCT provides clear advantages over other techniques in terms of its high-speed scans with high resolution, the ability to perform an advanced imaging analysis, and more accurate segmentation of the retinal layer compared with that of conventional OCT. Moreover, SD-OCT is capable of evaluating more detailed pathological changes.– In particular, an analysis of the macular inner retinal layer thickness is useful for detecting retinal ganglion cell loss in patients with glaucoma.– As part of our investigations of optic neuropathy, we previously reported that two patients showed rapid thinning of the ganglion cell complex (GCC) starting early after the onset of paediatric optic neuritis. In patients with optic neuritis, atrophy of the GCC occurs due to the apoptosis of retinal ganglion cells induced by demyelination beginning early after the onset of the disease. Our results revealed that the papillomacular bundle and cpRNFL suffer progressive loss even after treatment, and these changes are irreversible. Syc et al. also reported that ganglion cell layer and inner plexiform layer measurement are useful for evaluating the retinal thickness in the acute stage of optic neuritis. Therefore, we hypothesised that measurement of the macular inner retinal thickness would be able to detect the retinal ganglion cell loss at an early stage in NAION patients with severe disc swelling. Recently, a few studies utilizing SD-OCT have reported that the GCC thickness is reduced in NAION patients.– However, to our knowledge, there have been no reports of the time course of changes in NAION using the GCC thickness, which is considered to be unaffected by optic disc swelling. Thus, the purpose of the present study was to evaluate the time course of the GCC thickness using SD-OCT in patients with NAION.

Materials and methods

Patients with NAION diagnosed by ophthalmic examination agreed to participate in this study at the Department of Ophthalmology in Kawasaki Medical School Hospital. Normal subjects recruited as an age-matched control group were also enrolled. The study protocol adhered to the tenets of the Declaration of Helsinki and was approved by the institutional review board of Kawasaki Medical School. All patients underwent ocular examinations, including measurements of the best-corrected visual acuity, a slit-lamp examination, intraocular pressure measured with Goldmann applanation tonometry, the critical flicker frequency (CFF) using the Handy Flicker HF (Neitz Instruments Co., Ltd., Tokyo, Japan), funduscopy, fundus photography, fluorescein fundus angiography (FA), visual field tests using a Humphrey field analyser (Carl Zeiss Meditec, Dublin, CA, USA), Goldmann perimetry (Haag-Streit, Bern, Switzerland), SD-OCT, and magnetic resonance imaging. Normal control subjects underwent evaluations with a Humphrey field analyser using the central 30-2 Swedish Interactive Threshold Algorithm (SITA) program. A normal visual field was defined as the absence of any cluster of at least three points with p < 5%, one point with p < 0.5% or 1% on the pattern deviation probability plot, excluding the two points above and below the blind spot and within the normal limits in the glaucoma hemifield test and the 95% confidence interval. Reliable visual field results obtained with the Humphrey field analyser were defined as those with a fixation loss of less than 20% and false-positive and false-negative errors of less than 20%. The inclusion criteria for the normal control subjects were as follows: best-corrected visual acuity 20/40 or better, range of spherical refractive power from −5.75 dioptres (D) to +2.75 D, cylinder refractive power within ±3.00 D, intraocular pressure <22 mm Hg, and no history of intraocular surgery or trauma, retinal diseases including diabetic retinopathy, optic nerve diseases such as glaucoma, or any other disease affecting the visual field. The patients with moderate cataracts affecting the quality of SD-OCT images were also excluded.

Measurement of the GCC and cpRNFL thicknesses using SD-OCT

The SD-OCT examinations were performed using an RTVue-100 (Optovue, Fremont, CA, USA) device at the initial visit and at 1, 3, 6, and 12 months. The specifications for SD-OCT were such that the light source was a 840-nm superluminescent diode with a spectrum band width of 50 nm, axial resolution of 5.0 μm, A-scan/second of 26,000, and a focus range of −15.00 D to +20.00 D. The RTVue-100 software program version 4.0 was used for the data analysis. A GCC protocol was used to obtain the GCC thickness and parameters. The GCC measurements consisted of one horizontal line scan 7 mm in length (467 A-scans) and 15 vertical line scans 7 mm in length (each 400 A-scans) taken at 0.5-mm intervals. The centre of the measurement was shifted 0.75 mm temporally and covered a 7 × 7 mm rectangular area. This scan configuration provided 14,810 A-scans in 0.58 s. The GCC thickness was defined as the distance between the inner limiting membrane (ILM) and the outer border of the inner plexiform layer (IPL) (Figure 1A). The GCC measurements included the GCC thickness as a total, the superior and inferior hemiretinas, and GCC parameters such as the focal loss volume (FLV) and global loss volume (GLV). The FLV was represented as a focal thinning of the GCC within the scan area. The GLV was represented as a global thinning of the GCC in the scan area.
Figure 1.

Measurements of the GCC and cpRNFL thicknesses using the RTVue-100. (A) The GCC protocol. The GCC measurements consisted of one horizontal line scan 7 mm in length and 15 vertical line scans 7 mm in length taken at 0.5-mm intervals in a 7 × 7 mm area. The GCC thickness was defined as the distance between the inner limiting membrane and the outer border of the inner plexiform layer. (B) The ONH protocol. The ONH measurements were performed with 13 concentric circle ring scans and 12 radial line scans. GCC = ganglion cell complex; cpRNFL = circumpapillary retinal nerve fibre layer; ONH: optic nerve head map; RE: right eye.

The optic nerve head map (ONH) protocol was used to obtain the cpRNFL thickness and optic disc parameters. This protocol was based on the three-dimensional baseline mode where a 6 × 6 mm area scan was centred on the optic disc. The shape of the optic disc margin and anchoring point of the retinal pigment epithelium were automatically defined according to the three-dimensional baseline mode. Then, 13 concentric circle ring scans of 1.3 to 4.9 mm in diameter (425–965 A-scans each) and 12 radial line scans of 3.4 mm (452 A-scans each) were centred on the optic disc in a 4.9 mm area. The cpRNFL thickness on a circle at 3.45 mm in diameter from the centre of the optic disc was calculated (Figure 1B). The ONH measurements included the total cpRNFL thickness and superior and inferior hemiretinas. Measurements of the GCC and cpRNFL thicknesses using the RTVue-100. (A) The GCC protocol. The GCC measurements consisted of one horizontal line scan 7 mm in length and 15 vertical line scans 7 mm in length taken at 0.5-mm intervals in a 7 × 7 mm area. The GCC thickness was defined as the distance between the inner limiting membrane and the outer border of the inner plexiform layer. (B) The ONH protocol. The ONH measurements were performed with 13 concentric circle ring scans and 12 radial line scans. GCC = ganglion cell complex; cpRNFL = circumpapillary retinal nerve fibre layer; ONH: optic nerve head map; RE: right eye. The significance maps of the GCC and cpRNFL thickness are presented in comparison with the age-matched normal control database. The map is colour-coded. The colour code was divided into three colours, where green represents a value within the normal limits (p value 5–95%), yellow represents a borderline value (p value <5%), and red represents a value outside of normal (p value <1%). The GCC and cpRNFL thickness measurements were performed several times, and the most reliable data were selected. Images with signal strength index scores <45 or with segmentation errors were excluded. The SD-OCT examinations were performed by experienced technicians (K.G., S.A.), and the results were analysed by neuro-ophthalmology specialists (A.M., Y.I.).

Statistical analysis

The statistical analyses were performed using the Statistical Package for Social Science software package version 22.0 (SPSS, IBM, Tokyo, Japan). The Mann-Whitney U test was used to detect differences in the characteristics between normal control subjects and NAION patients. The GCC and cpRNFL thicknesses were compared with those of normal control subjects using a one-way analysis of variance (one-way ANOVA). Steel and Tukey post hoc multiple comparisons were used if there was a significant difference in the one-way ANOVA. A statistically significant difference was defined by a value of p < 5%.

Results

Five patients with NAION and 41 normal control subjects were included in this study. The clinical data for NAION patients are shown in Table 1. The NAION patients were three males and two females with an average age of 66.8 ± 7.8 years. Their average spherical equivalent was 0.80 ± 1.27, and the average disease duration was 8.6 ± 8.5 days. The normal control subjects were 14 males and 27 females with an average age of 63.0 ± 7.6 years (51 to 77 years). Their average refractive error in spherical equivalents was −0.38 ± 1.68 (+2.25 to −5.75 D). There was no significant difference in the age or refractive error between NAION eyes and normal control eyes. There was a significant difference between groups in both the mean deviation and pattern standard deviation of the visual field parameters (Table 2).
Table 1.

The clinical data for the patients with non-arteritic anterior ischaemic optic neuropathy.

Patient numberAgeGenderAffected eyeRefractive error (D) (spherical equivalents)Disease duration (days)Visual field loss
166FL2.752.0Inferior altitudinal loss
258ML0.503.0Diffuse visual field loss
377FL0.003.0Central scotoma and inferior altitudinal field loss
461ML−0.5014.0Inferior altitudinal field loss
572MR1.2521.0Diffuse visual field loss

Note. M = male; F = female; D = dioptres, R = right; L = left.

Table 2.

The demographic characteristics of the normal control subjects and patients with NAION.

CharacteristicNAION patients (n = 5)Normal controls (n = 41)p values
Age (years)66.8 ± 7.863.0 ± 7.60.437
Gender (M:F)3:214:271.00
Refractive error (D)0.80 ± 1.27−0.38 ± 1.680.525
MD (dB)−10.25 ± 8.730.49 ± 0.920.001
PSD (dB)9.25 ± 4.511.51 ± 0.240.001

Note. M = male; F = female; D = dioptres; NAION = non-arteritic anterior ischaemic optic neuropathy; MD = mean deviation; PSD = pattern standard deviation; dB = decibel.

The clinical data for the patients with non-arteritic anterior ischaemic optic neuropathy. Note. M = male; F = female; D = dioptres, R = right; L = left. The demographic characteristics of the normal control subjects and patients with NAION. Note. M = male; F = female; D = dioptres; NAION = non-arteritic anterior ischaemic optic neuropathy; MD = mean deviation; PSD = pattern standard deviation; dB = decibel. Table 3 shows the time course of GCC thickness, its parameters, and the cpRNFL thickness. The total GCC thicknesses in the NAION patients, at 1, 3, 6, and 12 months, were significantly reduced compared with that of the normal controls (p < 0.01) and decreased over time. Thinning of the superior and inferior GCC thicknesses was observed at 1 and 3 months, respectively, compared with that of the normal controls (p < 0.01). In addition, the total and superior GCC thicknesses at 1, 3, 6, and 12 months in the NAION patients were significantly reduced compared with those at the initial visit (p < 0.05) (Figure 2A).
Table 3.

The time course of the GCC and cpRNFL thicknesses determined using SD-OCT in patients with NAION.

ThicknessInitial visit1 month3 months6 months12 monthsNormal controlsp values
GCC thickness (μm)       
Total96.49 ± 9.14 (0.72%)84.28 ± 4.76** (−12.03%)74.26 ± 3.30** (−22.49%)71.23 ± 5.50** (−25.64%)69.51 ± 6.13** (−27.44%)95.80 ± 5.751.000/0.004/0.002/0.002/0.002
Superior94.43 ± 7.63 (−1.35%)77.03 ± 8.59** (−19.53%)67.17 ± 6.12** (−29.84%)63.63 ± 5.32** (−33.53%)61.03 ± 5.74** (−36.24%)95.73 ± 5.970.993/0.009/0.002/0.002/0.002
Inferior98.52 ± 10.86 (2.74%)91.35 ± 7.45 (−4.73%)81.36 ± 9.47** (−15.16%)78.85 ± 11.94** (−17.78%)77.99 ± 12.45** (−18.67%)95.89 ± 6.280.999/0.407/0.007/0.004/0.005
GCC parameters (%)       
FLV1.58 ± 0.72*7.25 ± 2.39**9.25 ± 2.42**10.30 ± 2.16**11.17 ± 2.59**0.52 ± 0.550.013/0.002/0.002/0.002/0.002
GLV5.73 ± 3.3014.47 ± 2.88**22.57 ± 3.71**26.89 ± 6.60**27.50 ± 6.92**4.02 ± 2.760.760/0.002/0.002/0.005/0.002
cpRNFL thickness (μm)       
Total190.79 ± 43.47** (78.38%)138.26 ± 39.95 (29.27%)100.08 ± 37.89 (−6.43%)82.96 ± 12.50** (−22.43%)79.50 ± 16.30** (−25.67%)106.96 ± 7.540.002/0.165/0.165/0.002/0.002
Superior202.20 ± 41.84** (91.24%)135.17 ± 55.25 (27.84%)93.81 ± 52.00 (−11.27%)74.68 ± 14.24** (−29.37%)70.21 ± 17.93** (−33.60%)106.73 ± 8.170.002/0.339/0.140/0.003/0.002
Inferior179.38 ± 49.75** (65.81%)143.71 ± 32.83* (32.84%)106.35 ± 26.64 (−1.69%)91.24 ± 18.23 (−15.66%)88.79 ± 18.36* (−17.93%)108.18 ± 8.460.002/0.034/0.990/0.118/0.018

Note. GCC = ganglion cell complex; cpRNFL = circumpapillary retinal nerve fibre layer; SD-OCT = spectral-domain optical coherence tomography; NAION = non-arteritic anterior ischaemic optic neuropathy; FLV = focal loss volume; GLV = global loss volume.

*p < 0.05, **p < 0.01; Steel’s post hoc multiple comparison test.

GCC and cpRNFL thicknesses (%): percentage of increase (positive values) or decrease (negative values) in NAION eyes compared with normal control eyes.

Figure 2.

The time course of SD-OCT parameters in the NAION patients. (A) The GCC thickness. There was a significant reduction of the total and superior GCC thicknesses observed at 1 month compared with those at the initial visit (*p < 0.05 and **p < 0.01, respectively). (B) The GCC parameters. The FLV and GLV were significantly increased at 1 month compared with the initial visit (**p < 0.01). (C) The cpRNFL thickness. Each cpRNFL thickness was significantly reduced at 1 month compared with the value at the initial visit (total and superior: **p < 0.01, inferior: *p < 0.05). SD-OCT = spectral domain optical coherence tomography; NAION = non-arteritic anterior ischaemic optic neuropathy; FLV = focal loss volume; GLV = global loss volume.

The time course of the GCC and cpRNFL thicknesses determined using SD-OCT in patients with NAION. Note. GCC = ganglion cell complex; cpRNFL = circumpapillary retinal nerve fibre layer; SD-OCT = spectral-domain optical coherence tomography; NAION = non-arteritic anterior ischaemic optic neuropathy; FLV = focal loss volume; GLV = global loss volume. *p < 0.05, **p < 0.01; Steel’s post hoc multiple comparison test. GCC and cpRNFL thicknesses (%): percentage of increase (positive values) or decrease (negative values) in NAION eyes compared with normal control eyes. The FLV was 1.58 ± 0.72% at the initial visit, 7.25 ± 2.39% at 1 month, 9.25 ± 2.42% at 3 months, 10.30 ± 2.16% at 6 months, and 11.17 ± 2.59% at 12 months, and increased over time. The FLVs in the NAION patients at the initial visit and at 1, 3, 6, and 12 months were significantly increased compared with the average of 0.52 ± 0.55% of the normal controls (at the initial visit: p < 0.05; 1, 3, 6, and 12 months: p < 0.01). Similarly, the GLVs at 1, 3, 6, and 12 months were significantly increased compared with those of the normal controls (p < 0.01) and increased over time. In addition, the FLVs and GLVs at 1, 3, 6, and 12 months in the NAION patients were significantly increased compared with the initial visit (p < 0.01) (Figure 2B). The total cpRNFL thickness at the initial visit in the NAION patients was significantly increased compared with that of the normal controls, and the values at 6 and 12 months were significantly reduced compared with those of the normal controls (p < 0.01). Thinning of the superior and inferior cpRNFL thicknesses were observed at 6 and 12 months, respectively (p < 0.01 and p < 0.05, respectively). In addition, the total and superior cpRNFL thicknesses at 1, 3, 6, and 12 months in the NAION patients were significantly reduced compared with that at the initial visit (p < 0.01) (Figure 2C). The time course of SD-OCT parameters in the NAION patients. (A) The GCC thickness. There was a significant reduction of the total and superior GCC thicknesses observed at 1 month compared with those at the initial visit (*p < 0.05 and **p < 0.01, respectively). (B) The GCC parameters. The FLV and GLV were significantly increased at 1 month compared with the initial visit (**p < 0.01). (C) The cpRNFL thickness. Each cpRNFL thickness was significantly reduced at 1 month compared with the value at the initial visit (total and superior: **p < 0.01, inferior: *p < 0.05). SD-OCT = spectral domain optical coherence tomography; NAION = non-arteritic anterior ischaemic optic neuropathy; FLV = focal loss volume; GLV = global loss volume. Figure 3 shows the time course of the mean ratio of the NAION eyes to the normal control eyes in terms of the GCC and cpRNFL thicknesses. The GCC thicknesses did not show any significant change at the initial visit, but were reduced over time. At 12 months, the average loss rate of the total GCC thickness was 27.44%, that of the superior GCC thickness was 36.24%, and that of the inferior GCC thickness was 18.67% (Figure 3A). The cpRNFL thicknesses showed a significant increase at the initial visit by 78.38% on total, 91.24% in the superior region, and 65.81% in the inferior region. The cpRNFL thicknesses were reduced over time, and the loss rates were 25.67% on total, 33.60% in the superior region, and 17.93% in the inferior region at 12 months (Figure 3B).
Figure 3.

The time course of the mean ratio of the GCC and cpRNFL thickness in the NAION eyes to the normal control eyes. (A) The GCC thickness. The reduction rate of the GCC thickness at 12 months was the highest in the superior region. (B) The cpRNFL thickness. The superior cpRNFL thickness was significantly increased at the initial visit, and the loss rate was the highest at 12 months.

The time course of the mean ratio of the GCC and cpRNFL thickness in the NAION eyes to the normal control eyes. (A) The GCC thickness. The reduction rate of the GCC thickness at 12 months was the highest in the superior region. (B) The cpRNFL thickness. The superior cpRNFL thickness was significantly increased at the initial visit, and the loss rate was the highest at 12 months.

Case reports

Case 1

A 66-year-old female with hypertension was referred to us with 2-day history of acute left visual loss. Her corrected visual acuity was 1.5 in the right eye and 1.2 in the left eye. Her intraocular pressure was 13 mm Hg in the right eye and 11 mm Hg in the left eye. The pupil reaction was incomplete in the left eye and a relative afferent pupillary defect (RAPD) OS was present. The CFF was 35 Hz in the right eye and 30 Hz in the left eye. Optic disc swelling was observed in the fundus examination. The FA images showed leakage of the optic disc (Figure 4A). Inferior altitudinal field loss was demonstrated by a Humphrey field analyser (Figure 4B).
Figure 4.

A 66-year-old female with inferior altitudinal field loss (case 1). (A) Left: a fundus photograph showed optic disc swelling; Right: FA images showed leakage of the optic disc. (B) Left: grey scale; Right: pattern deviation. The Humphrey visual field test showed inferior altitudinal field loss along the horizontal meridian. (C) Top: the cpRNFL significance map; Bottom: the GCC significance map. The cpRNFL significance map was increased at the initial visit and at 1 month due to optic disc swelling, and a significant reduction was observed at 3 months in the superior temporal sectors. The GCC significance map at 1 month showed thinning of the superior hemifield along the horizontal meridian corresponding to the inferior altitudinal field loss. The thinning area gradually spread over time. LE = left eye.

The GCC significance map indicated thinning of the superior hemisphere corresponding to the inferior hemifield loss at 1 month after the onset, and the thinning area along the horizontal meridian gradually expanded over time. On the other hand, the cpRNFL significance map showed a significant reduction in the superior temporal sectors at 3 months (Figure 4C). A 66-year-old female with inferior altitudinal field loss (case 1). (A) Left: a fundus photograph showed optic disc swelling; Right: FA images showed leakage of the optic disc. (B) Left: grey scale; Right: pattern deviation. The Humphrey visual field test showed inferior altitudinal field loss along the horizontal meridian. (C) Top: the cpRNFL significance map; Bottom: the GCC significance map. The cpRNFL significance map was increased at the initial visit and at 1 month due to optic disc swelling, and a significant reduction was observed at 3 months in the superior temporal sectors. The GCC significance map at 1 month showed thinning of the superior hemifield along the horizontal meridian corresponding to the inferior altitudinal field loss. The thinning area gradually spread over time. LE = left eye.

Case 5

A 72-year-old male with diabetes and stenosis of the internal carotid artery was referred to us with 3-week history of acute unilateral visual loss. His corrected visual acuity was 0.3 in the right eye and 1.2 in the left eye. His intraocular pressure was 11 mm Hg in the right eye and 13 mm Hg in the left eye. The pupil reaction was incomplete in the right eye and RAPD OD was present. The CFF was 23 Hz in the right eye and 32 Hz in the left eye. Severe optic disc swelling with splinter haemorrhage was observed in the fundus examination. The FA images showed leakage of the optic disc and a filling delay in the inferior area (Figure 5A). Diffuse visual field loss denser superiorly was detected by a Humphrey field analyser (Figure 5B).
Figure 5.

A 72-year-old male with diffuse visual field loss that was more dense superiorly (case 5). (A) Left: a fundus photograph showed severe optic disc swelling with splinter haemorrhage; Right: FA images showed the leakage of the optic disc and a filling delay in the inferior region. (B) Left: grey scale; Right: pattern deviation. The Humphrey visual field test showed diffuse visual field loss that was more dense in the superiorly. (C) Top: the cpRNFL significance map; Bottom: the GCC significance map. The cpRNFL significance map was increased until 3 months due to optic disc swelling, and significant thinning was observed in the inferior sectors at 6 months and in the superior and inferior sectors at 12 months. The GCC significance map showed thinning of the area at 1 month after the onset. Moreover, the GCC thickness at 3 months indicated predominant thinning of the inferior hemifield corresponding to the diffuse visual field loss, which was denser in the superior region. However, the thinning area expanded beyond the horizontal meridian over time. The GCC significance map showed good agreement with the visual field loss pattern. RE = right eye.

The GCC significance map indicated predominant thinning of the inferior hemifield corresponding to the diffuse visual field loss denser superiorly at 3 months after the onset. However, the thinning area expanded beyond the horizontal meridian over time. On the other hand, the cpRNFL significance map showed a significant reduction in the inferior sectors beginning at 6 months and in the superior and inferior sectors at 12 months (Figure 5C). A 72-year-old male with diffuse visual field loss that was more dense superiorly (case 5). (A) Left: a fundus photograph showed severe optic disc swelling with splinter haemorrhage; Right: FA images showed the leakage of the optic disc and a filling delay in the inferior region. (B) Left: grey scale; Right: pattern deviation. The Humphrey visual field test showed diffuse visual field loss that was more dense in the superiorly. (C) Top: the cpRNFL significance map; Bottom: the GCC significance map. The cpRNFL significance map was increased until 3 months due to optic disc swelling, and significant thinning was observed in the inferior sectors at 6 months and in the superior and inferior sectors at 12 months. The GCC significance map showed thinning of the area at 1 month after the onset. Moreover, the GCC thickness at 3 months indicated predominant thinning of the inferior hemifield corresponding to the diffuse visual field loss, which was denser in the superior region. However, the thinning area expanded beyond the horizontal meridian over time. The GCC significance map showed good agreement with the visual field loss pattern. RE = right eye.

Discussion

Our results indicated that the GCC thickness in NAION patients was already significantly reduced at 1 month after the onset compared with that of the normal controls, whereas the cpRNFL thickness was only found to be significantly reduced at 6 months. We found that the retinal ganglion cell loss in NAION patients had occurred within 1 month after the onset, and the GCC thickness further decreased over time. Therefore, we demonstrated that GCC thickness measurement is capable of detecting the ganglion cell loss earlier after the onset than cpRNFL thickness measurement. Some authors have previously reported the time course of cpRNFL thickness in NAION patients using OCT.– For example, Savini et al. and Bellusci et al. reported that the cpRNFL thickness during the acute phase in NAION patients was increased in all quadrants due to severe disc swelling. The cpRNFL thickness in the chronic phase was reduced in all quadrants. Contreras et al. reported that the cpRNFL thickness during the acute phase in the affected eye was 200.9 ± 52.3 μm (96.4%), which was significantly increased compared with that in the unaffected eye. The percentage of cpRNFL thickness loss was 42.3% at 6 months, when its reduction reached a plateau. The cpRNFL thickness loss at 6 months in each quadrant was 51.5% in the superior, 28.5% in the nasal, 41.2% in the inferior, and 38.2% in the temporal, and the reduction in the superior quadrant was more apparent than that in other quadrants. Contreras et al. reported that this finding was in accordance with the high prevalence of inferior visual field loss in NAION patients. In our study, the total cpRNFL thickness at the initial visit in patients with NAION was significantly increased by 78.38% compared with that of the normal controls, and the cpRNFL thickness at 6 and 12 months was significantly decreased by 22.43% and 25.67%. The reduction rate of the superior cpRNFL thickness was highest in the cpRNFL parameters, and the value at 12 months was 33.60%. This result was in agreement with the high percentage of patients who had an inferior hemifield loss in our study. In addition, the thinning of the cpRNFL thickness reached a plateau at 6 months, similar to the finding in a previous report that utilized Stratus OCT. It is clear from our results and the previous reports that cpRNFL measurement in NAION patients cannot detect the retinal ganglion cell and axonal loss during the acute phase. This is because the cpRNFL thickness was significantly increased by disc swelling in the acute stage, resulting in masked retinal ganglion cell loss. In fact, the ratio of superior cpRNFL thickness was the most increased at the initial visit and was the most decreased at 12 months. These results suggest that the increase in the cpRNFL thickness during the acute stage implies a degree of ischaemia. Using SD-OCT, Aggarwal et al. reported that the pattern of altitudinal GCC loss in chronic NAION corresponded to the visual field loss. Gonul et al. reported that the GCC thickness in chronic NAION was significantly reduced compared with that in normal controls. Furthermore, the FLV and GLV of the GCC parameters had the strongest abilities to detect ganglion cell loss among the various OCT parameters and were comparable to the cpRNFL thickness. Larrea et al. reported that the average GCC thickness determined using Cirrus OCT was 68.33 μm during the acute phase and 54.87 μm at 6 months, and there was a significant reduction between the acute and chronic phases. The percentage reduction in the average GCC thickness from the acute to the chronic phases was 19.7%. Moreover, Larrea et al. found that a GCC analysis in the macular region could detect early axonal damage during the acute onset of NAION. To our knowledge, this is the first report to include a detailed time course of the GCC thickness in NAION patients. Our study revealed that the total GCC thickness was significantly reduced, although the cpRNFL thickness was increased, at 1 month after the onset. The percentage of total GCC loss compared with the value in normal controls was 12.03% at 1 month and 27.44% at 12 months. The loss rate of the superior GCC thickness was the highest, and the value at 12 months averaged 36.24%. This result was consistent with the finding that the loss rate of the cpRNFL thickness was the highest in the superior area (33.60%). In addition, FLV and GLV parameters were significantly increased at the initial visit and at 1 month, respectively. This result suggests that ganglion cell loss has already occurred at the acute stage, whereas the cpRNFL thickness was significantly increased due to optic disc swelling. Therefore, we consider that the FLV parameter can detect the ganglion cell loss earlier than any other GCC or cpRNFL parameter. Moreover, the GCC significance maps in our patients indicated that the thinning area corresponded well with the visual field loss pattern, similar to a previous report. The pattern of GCC thinning may have reflected detailed structural changes caused by ischaemia of the optic nerve. In experimental AION models and histological studies, Lee et al. reported that RGC axons showed severe degenerative changes within 1 week after the ischaemic event. Slater et al. reported that apoptosis of the RGC occurs maximally in the 2 to 3 weeks after an infarct. In experimental animal models of AION evaluated using SD-OCT, Ho et al. reported that the manually segmented GCC thickness 1 day after an ischaemic event using circular scan centred at the optic disc showed a 31% increase compared with that of the normal controls. The value was thinner at 2 weeks and showed a gradual thinning, which reached a plateau at 3 weeks, when it showed a reduction of 11%. Maekubo et al. reported that the automatically segmented inner retinal thickness in 3 mm diameter circle area centred at the optic disc significantly increased until 1 week after insult, returned to the baseline at 2 weeks, and decreased gradually until 3 months. Our present results showing that ganglion cell loss was detected by the FLV parameter at the initial visit are consistent with the findings in experimental models and histological studies. There are several limitations associated with the present study. First, this study included a small number of patients. Therefore, a subgroup analysis could not be performed by classification according to the pattern of visual field loss due to the small sample size. Second, optic disc swelling at the initial visit has the potential to affect the structure of the nasal retina in the macular region. Third, in some patients with NAION, subretinal fluid associated with NAION has been observed in the subfoveal space, so there is a possibility that an error in the analysis of the GCC segmentation accuracy might occur. Therefore, GCC measurements may not be accurate in all patients with NAION. Further research with a larger sample size is necessary to fully elucidate the time course of the GCC thickness in patients with each visual field loss pattern category. In conclusion, measurements of the GCC thickness and the FLV and GLV parameters using SD-OCT are suitable for the objective evaluation and early detection of ganglion cell loss during the acute stage of NAION. Moreover, GCC thickness measurements can demonstrate the ganglion cell loss in the early stage when cpRNFL measurements cannot detect the axonal loss due to optic disc swelling.

Funding

Japan Society for the Promotion of Science (JPSP) provided financial support in the form of KAKENHI Grants-in-Aid funding (grant number 26462703). The sponsor had no role in the design or conduct of this research.
  28 in total

1.  Incidence of nonarteritic anterior ischemic optic neuropathy.

Authors:  M G Hattenhauer; J A Leavitt; D O Hodge; R Grill; D T Gray
Journal:  Am J Ophthalmol       Date:  1997-01       Impact factor: 5.258

Review 2.  Optic disk risk factors for nonarteritic anterior ischemic optic neuropathy.

Authors:  R M Burde
Journal:  Am J Ophthalmol       Date:  1993-12-15       Impact factor: 5.258

3.  Enhanced optical coherence tomography imaging by multiple scan averaging.

Authors:  B Sander; M Larsen; L Thrane; J L Hougaard; T M Jørgensen
Journal:  Br J Ophthalmol       Date:  2005-02       Impact factor: 4.638

4.  Visual field abnormalities in nonarteritic anterior ischemic optic neuropathy: their pattern and prevalence at initial examination.

Authors:  Sohan Singh Hayreh; Bridget Zimmerman
Journal:  Arch Ophthalmol       Date:  2005-11

5.  Detection and quantification of retinal nerve fiber layer thickness in optic disc edema using stratus OCT.

Authors:  Giacomo Savini; Costantino Bellusci; Michele Carbonelli; Maurizio Zanini; Valerio Carelli; Alfredo A Sadun; Piero Barboni
Journal:  Arch Ophthalmol       Date:  2006-08

6.  Subretinal fluid from anterior ischemic optic neuropathy demonstrated by optical coherence tomography.

Authors:  Thomas R Hedges; Laurel N Vuong; Alberto O Gonzalez-Garcia; Carlos E Mendoza-Santiesteban; Maria Luz Amaro-Quierza
Journal:  Arch Ophthalmol       Date:  2008-06

7.  [Two cases of optic neuritis in children with rapid thinning of the ganglion cell complex].

Authors:  Katsutoshi Goto; Kenichi Mizukawa; Atsushi Miki; Tsutomu Yamashita; Syunsuke Araki; Junichi Kiryu
Journal:  Nippon Ganka Gakkai Zasshi       Date:  2013-12

8.  Severe, early axonal degeneration following experimental anterior ischemic optic neuropathy.

Authors:  Gun Ho Lee; Madison P Stanford; Mohammad A Shariati; Jeffrey H Ma; Yaping Joyce Liao
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-09-23       Impact factor: 4.799

9.  Comparison of the ganglion cell complex and retinal nerve fibre layer measurements using Fourier domain optical coherence tomography to detect ganglion cell loss in non-arteritic anterior ischaemic optic neuropathy.

Authors:  Saban Gonul; Bengu Ekinci Koktekir; Berker Bakbak; Sansal Gedik
Journal:  Br J Ophthalmol       Date:  2013-06-12       Impact factor: 4.638

10.  Detection of macular ganglion cell loss in glaucoma by Fourier-domain optical coherence tomography.

Authors:  Ou Tan; Vikas Chopra; Ake Tzu-Hui Lu; Joel S Schuman; Hiroshi Ishikawa; Gadi Wollstein; Rohit Varma; David Huang
Journal:  Ophthalmology       Date:  2009-09-10       Impact factor: 12.079

View more
  8 in total

1.  Evaluation of Choroidal Thickness in Non-arteritic Anterior Ischaemic Optic Neuropathy at the Acute and Chronic Stages.

Authors:  Saban Gonul; Sansal Gedik; Bengu Ekinci Koktekir; Kamil Yavuzer; Suleyman Okudan
Journal:  Neuroophthalmology       Date:  2016-06-30

2.  The Central Bright Spot Sign: A Potential New MR Imaging Sign for the Early Diagnosis of Anterior Ischemic Optic Neuropathy due to Giant Cell Arteritis.

Authors:  P Remond; A Attyé; A Lecler; L Lamalle; N Boudiaf; F Aptel; A Krainik; C Chiquet
Journal:  AJNR Am J Neuroradiol       Date:  2017-05-11       Impact factor: 3.825

3.  Retinal Vessel Density in Optical Coherence Tomography Angiography in Optic Atrophy after Nonarteritic Anterior Ischemic Optic Neuropathy.

Authors:  Chun-Hsiu Liu; Ling-Yuh Kao; Ming-Hui Sun; Wei-Chi Wu; Henry Shen-Lih Chen
Journal:  J Ophthalmol       Date:  2017-02-19       Impact factor: 1.909

4.  Variable structure and function relationship of compressive optic neuropathy at the time of diagnosis.

Authors:  Poramaet Laowanapiban; Niphon Chirapapaisan; Sumitra Kemahayung; Mathuwan Srikong
Journal:  Clin Ophthalmol       Date:  2019-08-22

5.  Peripapillary and Macular Flow Changes in Nonarteritic Anterior Ischemic Optic Neuropathy (NAION) by Optical Coherence Tomography Angiography (OCT-A).

Authors:  Juejun Liu; Changzheng Chen; Lu Li; Zuohuizi Yi; Hongmei Zheng
Journal:  J Ophthalmol       Date:  2020-11-02       Impact factor: 1.909

6.  Association between Optical Coherence Tomography Measurements and Clinical Parameters in Idiopathic Intracranial Hypertension.

Authors:  Priscilla Fernandes Nogueira; Gustavo Coelho Caiado; Carolina P B Gracitelli; Fernando Meister Martins; Felipe Chaves Duarte Barros; Sandro Luis De Andrade Matas; Sérgio Henrique Teixeira; Luciana da Cruz Noia; Danilo Andriatti Paulo
Journal:  J Ophthalmol       Date:  2021-01-25       Impact factor: 1.909

7.  Analysis of Macular Microperimetry Characteristics in Non-Arteritic Anterior Ischemic Optic Neuropathy.

Authors:  Hongxia Gong; Huilan Wang; Nan Zhou
Journal:  Med Sci Monit       Date:  2020-11-20

8.  Optic Nerve Head Microcirculation in Eyes with Vogt-Koyanagi-Harada Disease Accompanied by Anterior Ischemic Optic Neuropathy.

Authors:  Yui Yamashita; Yuki Hashimoto; Kenichi Namba; Kazuomi Mizuuchi; Susumu Ishida
Journal:  Case Rep Ophthalmol       Date:  2021-11-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.